ConductScience.org, home

Trial · NCT03503474

COMBACTE-CDI Understanding the Burden of C. Difficile Infection

NCT03503474, Completed, University of Leeds; results first posted 2022-02-09

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. COMBACTE-CDI Understanding the Burden of C. Difficile Infection. Trials, record NCT03503474. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03503474

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
COMBACTE-CDI Understanding the Burden of C. Difficile Infection
NCT number
NCT03503474
Status
Completed
Enrollment
3,240 participants, actual
Lead sponsor
University of Leeds
Conditions
Clostridium Difficile Infection
Interventions
No intervention
First posted
2018-04-19
Last updated
2022-02-09
Results first posted
2022-02-09

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe Number of Cases of CDI
Samples were received between July and December 2018 (at time of diarrheal episode) and test performed during that timeframe to identify the number of CDI cases (positive test result) and the number of CDI negative controls (negative test result).
This outcome measure is to indicate the number of participants with a sample that returned a positive test result (=CDI cases) at the coordinating laboratory from the overall total number of participants. The number of CDI cases and negative controls are the number of participants with a sample that returned a positive or negative test result, respectively. Therefore the "CDI negative controls" arm did not return a positive test result. The proportion of participants that returned a positive test result compared to the total of participants (=number of participants in the "CDI cases" arm divided by the number of total participants in both arms) can be inferred from this outcome measure.

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYThe Number of Cases of CDI
Samples were received between July and December 2018 (at time of diarrheal episode) and test performed during that timeframe to identify the number of CDI cases (positive test result) and the number of CDI negative controls (negative test result).
The number of CDI cases and negative controls are the number of participants with a sample that returned a positive or negative test result, respectively. Therefore the CDI negative controls arms did not return a positive test result.
ParticipantsCOUNT_OF_PARTICIPANTS

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
The Number of Cases of CDICDI Cases103Participants
The Number of Cases of CDICDI Negative Controls0Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDCDI Cases103
Overall StudySTARTEDCDI Negative Controls3,050
Overall StudyCOMPLETEDCDI Cases103
Overall StudyCOMPLETEDCDI Negative Controls3,050
Overall StudyNOT COMPLETEDCDI Cases0
Overall StudyNOT COMPLETEDCDI Negative Controls0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityCDI Cases1488
Total, all-cause mortalityCDI Negative Controls24401
Total, other adverse eventsCDI Cases00
Total, other adverse eventsCDI Negative Controls00
Total, serious adverse eventsCDI Cases00
Total, serious adverse eventsCDI Negative Controls00

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
39535868DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
CDI Cases vs CDI Negative Controls: The Number of Cases of CDITrial comparisons
CDI Cases vs CDI Negative Controls: deaths from any causeTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03503474

GET https://conductscience.org/api/trials/v1/NCT03503474/registered